TacrolimusImmunosuppressive AgentsLiver TransplantationLiver DiseasesLiverLiver NeoplasmsCyclosporineLiver CirrhosisMycophenolic AcidKidney TransplantationMicrosomes, LiverGraft RejectionLiver RegenerationFatty LiverOintmentsLiver Function TestsGraft SurvivalMitochondria, LiverDrug-Induced Liver InjuryCalcineurinSirolimusCytochrome P-450 CYP3ALiver ExtractsLiver CirculationLiver Neoplasms, ExperimentalTreatment OutcomeDrug Therapy, CombinationLiver Failure, AcuteTime FactorsLiver AbscessLiving DonorsDrug MonitoringLiver Diseases, AlcoholicAdministration, TopicalDermatologic AgentsPancreas TransplantationKidneyAdrenal Cortex HormonesTransplantation, HomologousImmunosuppressionHepatectomyHepatocytesDose-Response Relationship, DrugDrug InteractionsEmollientsRetrospective StudiesLiver Cirrhosis, ExperimentalDermatitis, AtopicTacrolimus Binding Protein 1ALiver Cirrhosis, AlcoholicCytochrome P-450 Enzyme SystemAlanine TransaminaseAdministration, OralTissue DonorsLiver, ArtificialLiver GlycogenFollow-Up StudiesCarcinoma, HepatocellularSteroidsAntilymphocyte SerumEnd Stage Liver DiseaseRats, WistarRats, Inbred StrainsProspective StudiesArea Under CurveRNA, MessengerGraft vs Host DiseaseDrug Administration Schedule